hu14.18-interleukin-2 fusion protein

Definition / meaning of hu14.18-interleukin-2 fusion protein

An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.

Listed under:

Find More About 'hu14.18-interleukin-2 fusion protein'


The Web site of the National Cancer Institute (

Leave a Comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.